alexa Advances In Nanotechnology Based Drug Delivery System Of Curcumin
ISSN: 2167-0501

Biochemistry & Pharmacology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

International Conference on Pharmacognosy, Phytochemistry & Natural Products
October 21-23, 2013 Radisson Blu Plaza Hotel, Hyderabad, India

Rutuja Munot, Sneha Golle, Priyanka Rokade and Revan Karodi
Posters: Biochem & Pharmacol
DOI: 10.4172/2167-0501.S1.003
Curcumin, a naturally occuring polyphenolic compound, is known to have a wide range of therapeutic and pharmacological properties. Curcumin is bioactive ingredient of turmeric & it is use as spice and as nutritional supplement & isolated from rhizomes of Curcuma longa Linn. of family Zingiberaceae. It has a role as antioxidant, anti-inflammatory, anti-hyperlipidemic, anti-cancer, digestive, anti-allergic, antibacterial etc., but curcumin has main drawbacks such as instability, low solubility, poor bioavailability & rapid metabolism. Over a period of time, a lot of emphasis has been given to improve the biodistribution & all drawbacks of native curcumin, but it is only recently that application of the field of nanotherapeutics has significantly improved its therapeutic efficacy. Development of nanorange formulations of curcumin, popularly known as "Nanocurcumin." Nonotechnology drug delivery system of curcumin including liposomes, solid-lipid nanoparticles, micells, nanosuspension, nanoemulsion, self microemulsifying drug delivery system which provide promising result for curcumin to improve its biological activities. These attempts have given a strong platform to get all the biological benefits from this phytodrug, which was not significantly possible earlier. We also summarize the biological applications, patented technologies, and current status of the ongoing clinical trials related to nanocurcumin.
Rutuja Munot is studying in final year of in Pad. Dr. D. Y. Patil college of Pharmacy, India.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version